导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -1.24% | 2768/4773 |
| 近一周 | -2.05% | 3314/5465 |
| 近一月 | -4.76% | 3451/5421 |
| 近一季 | -7.20% | 2711/5231 |
| 近半年 | -3.18% | 2418/4920 |
| 近一年 | 3.37% | 2087/4394 |
| 近两年 | 50.33% | 1484/2954 |
| 近三年 | 34.62% | 920/2253 |
| 成立以来 | 258.79% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.89% 2948/4961 |
12.66% 2141/5312 |
- - |
- - |
| 2025 | 24.18% 1804/4813 |
0.66% 1799/3635 |
1.34% 2375/4076 |
20.66% 1939/4524 |
0.90% 1683/4813 |
| 2024 | 17.84% 647/3463 |
3.30% 600/2808 |
-0.65% 807/3014 |
17.42% 1190/3129 |
-2.21% 2000/3463 |
| 2023 | -8.60% 1033/2656 |
4.73% 881/2280 |
-4.22% 1096/2385 |
-2.74% 739/2515 |
-6.31% 1715/2655 |
| 2022 | -18.78% 756/2207 |
-12.76% 656/1919 |
7.01% 549/2016 |
-14.26% 1052/2113 |
1.47% 1255/2208 |
| 2021 | -1.84% 822/1822 |
-1.59% 518/1255 |
2.55% 998/1330 |
-5.22% 786/1466 |
2.62% 552/1822 |
| 2020 | 39.28% 339/1250 |
-9.69% 709/1028 |
13.10% 648/1067 |
17.04% 121/1164 |
16.51% 165/1184 |
| 2019 | 37.84% 327/1092 |
24.83% 490/754 |
3.03% 63/804 |
0.66% 491/850 |
6.48% 604/918 |
| 2018 | -19.75% 178/834 |
- - |
- - |
- - |
-11.85% 364/691 |
| 2017 | 30.57% 57/714 |
- - |
- - |
- - |
- - |
| 2016 | -4.72% 164/605 |
- - |
- - |
- - |
- - |
| 2015 | 0.07% 255/575 |
- - |
- - |
- - |
- - |
| 2014 | 59.16% 37/237 |
- - |
- - |
- - |
- - |
| 2013 | -10.47% 156/186 |
- - |
- - |
- - |
- - |
| 2012 | 11.98% 27/140 |
- - |
- - |
- - |
- - |
| 2011 | -19.50% 32/102 |
- - |
- - |
- - |
- - |
| 2010 | -17.58% 44/58 |
- - |
- - |
- - |
- - |
| 2009 | 83.53% 17/27 |
- - |
- - |
- - |
- - |
| 2008 | -62.44% 12/26 |
- - |
- - |
- - |
- - |
| 2007 | 115.44% 19/22 |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 长盛中证A100指数 VS. 长安沪深300非周期A(740101) |